These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15268661)

  • 1. Using antibodies in tumour immunotherapy.
    Schultes BC; Nicodemus CF
    Expert Opin Biol Ther; 2004 Aug; 4(8):1265-84. PubMed ID: 15268661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of metastasis.
    Dallal RM; Lotze MT
    Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hepatocellular carcinoma with the cellular tumor vaccines generated by in vitro modification of tumor cells with non gene transfer approaches.
    Wu S; Ma J; Che X; Liu Y; Wang H; Zhao J; Shen F; Xie T; Trojan J; Wu M; Guo Y
    Adv Exp Med Biol; 1998; 451():283-93. PubMed ID: 10026886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
    Zbar AP; Lemoine NR; Wadhwa M; Thomas H; Snary D; Kmiot WA
    Br J Cancer; 1998 Mar; 77(5):683-93. PubMed ID: 9514045
    [No Abstract]   [Full Text] [Related]  

  • 5. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-idiotype vaccine against cancer.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Immunol Lett; 2000 Sep; 74(1):51-8. PubMed ID: 10996628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological approaches to tumor therapy. Monoclonal antibodies, tumor vaccines, and anti-idiotypes.
    Hellström KE; Hellström I
    Targeted Diagn Ther; 1989; 2():1-39. PubMed ID: 2519542
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between induction of anti high molecular weight-melanoma associated antigen (HMW-MAA) immunity with mouse antiidiotypic monoclonal antibody (MoAb) MK2-23 and prolongation of survival in patients with melanoma.
    Chen ZJ; Yang H; Liu CC; Mittelman A; Ferrone S
    Pigment Cell Res; 1992; Suppl 2():113-22. PubMed ID: 1409413
    [No Abstract]   [Full Text] [Related]  

  • 11. Current approaches in ovarian cancer vaccines.
    Reinartz S; Wagner U
    Minerva Ginecol; 2004 Dec; 56(6):515-27. PubMed ID: 15729204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for immunotherapy of cancer.
    Melief CJ; Toes RE; Medema JP; van der Burg SH; Ossendorp F; Offringa R
    Adv Immunol; 2000; 75():235-82. PubMed ID: 10879286
    [No Abstract]   [Full Text] [Related]  

  • 13. Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
    Bhattachary-Chatterjee M; Nath Baral R; Chatterjee SK; Das R; Zeytin H; Chakraborty M; Foon KA
    Cancer Immunol Immunother; 2000 Jun; 49(3):133-41. PubMed ID: 10881692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer immunotherapy--current status].
    Kundig TM; Renner Ch; Knuth A
    Ther Umsch; 2006 Apr; 63(4):262-6. PubMed ID: 16689457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell lysate-pulsed dendritic cells are more effective than TCR Id protein vaccines for active immunotherapy of T cell lymphoma.
    Gatza E; Okada CY
    J Immunol; 2002 Nov; 169(9):5227-35. PubMed ID: 12391241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor vaccines and active specific immunotherapy].
    Schirrmacher V
    Internist (Berl); 1997 Nov; 38(11):1050-4. PubMed ID: 9453953
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccine and antibody-directed T cell tumour immunotherapy.
    Dermime S; Gilham DE; Shaw DM; Davidson EJ; Meziane el-K; Armstrong A; Hawkins RE; Stern PL
    Biochim Biophys Acta; 2004 Jul; 1704(1):11-35. PubMed ID: 15238242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-idiotype vaccines for immunotherapy.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo studies using bispecific antibodies (anti-CD3 x anti-idiotype) and CD28-induced costimulation in the BCL1 lymphoma.
    Demanet C; Brissinck J; De Jonge J; Thielemans K
    J Hematother; 1995 Oct; 4(5):363-8. PubMed ID: 8581370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes.
    Fagerberg J; Hjelm AL; Ragnhammar P; Frödin JE; Wigzell H; Mellstedt H
    Cancer Res; 1995 May; 55(9):1824-7. PubMed ID: 7728746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.